These drugs include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity for diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for weight management)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not solely a GLP-1 agonist
B., Klein, M., Kumar, A
Part D enrollees using a GLP-1 for type 2 diabetes, sleep apnea, or other Medicare-covered uses will continue accessing the drug through their Part D plan and paying their plans cost-sharing requirement, even if its more than the $50 copayment for GLP-1s for obesity under the Medicare GLP-1 Bridge
Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights
H.RichardJ
Cons: standard capsule (no liposomal or sustained-release technology), reduced form is more vulnerable to digestive degradation, does not use Setria branded glutathione
